Cutting edge research: clinical impact

The ACT government will spend $7.3 million on new gene technology which could open the door to drug therapies that can be adapted to individual patients based on their genetics and medical conditions.

Canberra Clinical Genomics director Professor Matthew Cook from ANU said the new centre would make a real difference to patients' lives.

The research could have the potential to help people suffering from a wide range of illnesses, from children with "devastating diseases" to those with inflammatory illnesses and even cancer

• Categorie

  • Onderwijs

• Licentie

  • Creative Commons-licentie - Naamsvermelding (hergebruik toegestaan)

• Bronvideo's

  • Toeschrijvingen bekijken